Arch, a16z back Alnylam co-founder’s next big RNA play


With backing from the likes of Arch Venture Partners and Andreessen Horowitz's health care fund, a16z Bio + Health, a new startup is planning to bundle together nearly all the RNA advances of the 21st century under one roof.

Previous State Street tells feds that delayed Brown Brothers Harriman deal still in play
Next Opioid settlement advisory board begins decision making process